Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

The Prodromes of Parkinson's disease.

Rees RN, Noyce AJ, Schrag A.

Eur J Neurosci. 2018 Nov 17. doi: 10.1111/ejn.14269. [Epub ahead of print]

PMID:
30447019
2.

Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study.

Balzer-Geldsetzer M, Ferreira J, Odin P, Bloem BR, Meissner WG, Lorenzl S, Wittenberg M, Dodel R, Schrag A.

BMC Neurol. 2018 Nov 5;18(1):185. doi: 10.1186/s12883-018-1184-3.

3.

Testing the MDS clinical diagnostic criteria for Parkinson's disease.

Schrag A.

Mov Disord. 2018 Oct;33(10):1518-1520. doi: 10.1002/mds.27543. No abstract available.

PMID:
30365218
4.

Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis.

Balint B, Killaspy H, Marston L, Barnes T, Latorre A, Joyce E, Clarke CS, De Micco R, Edwards MJ, Erro R, Foltynie T, Hunter RM, Nolan F, Schrag A, Freemantle N, Foreshaw Y, Green N, Bhatia KP, Martino D.

BJPsych Open. 2018 Sep 27;4(5):404-410. doi: 10.1192/bjo.2018.55. eCollection 2018 Sep.

5.

Can neuroimaging predict dementia in Parkinson's disease?

Lanskey JH, McColgan P, Schrag AE, Acosta-Cabronero J, Rees G, Morris HR, Weil RS.

Brain. 2018 Sep 1;141(9):2545-2560. doi: 10.1093/brain/awy211.

6.

An early diagnosis is not the same as a timely diagnosis of Parkinson's disease.

Rees RN, Acharya AP, Schrag A, Noyce AJ.

F1000Res. 2018 Jul 18;7. pii: F1000 Faculty Rev-1106. doi: 10.12688/f1000research.14528.1. eCollection 2018. Review.

7.

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents.

Schrag A, Martino D, Apter A, Ball J, Bartolini E, Benaroya-Milshtein N, Buttiglione M, Cardona F, Creti R, Efstratiou A, Gariup M, Georgitsi M, Hedderly T, Heyman I, Margarit I, Mir P, Moll N, Morer A, Müller N, Müller-Vahl K, Münchau A, Orefici G, Plessen KJ, Porcelli C, Paschou P, Rizzo R, Roessner V, Schwarz MJ, Steinberg T, Tagwerker Gloor F, Tarnok Z, Walitza S, Dietrich A, Hoekstra PJ; EMTICS Collaborative Group.

Eur Child Adolesc Psychiatry. 2018 Jul 7. doi: 10.1007/s00787-018-1190-4. [Epub ahead of print]

8.

Experience of care for Parkinson's disease in European countries: a survey by the European Parkinson's Disease Association.

Schrag A, Khan K, Hotham S, Merritt R, Rascol O, Graham L.

Eur J Neurol. 2018 Dec;25(12):1410-e120. doi: 10.1111/ene.13738. Epub 2018 Aug 16.

PMID:
29939446
9.

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.

Skorvanek M, Martinez-Martin P, Kovacs N, Zezula I, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Aviles-Olmos I, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Valkovic P, Goetz CG, Stebbins GT.

Parkinsonism Relat Disord. 2018 Jul;52:83-89. doi: 10.1016/j.parkreldis.2018.03.027. Epub 2018 Mar 28.

PMID:
29625875
10.

Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.

Weir S, Samnaliev M, Kuo TC, Tierney TS, Walleser Autiero S, Taylor RS, Schrag A.

Mov Disord. 2018 Jul;33(6):974-981. doi: 10.1002/mds.27302. Epub 2018 Mar 30.

PMID:
29603405
11.

Patient experiences of receiving a diagnosis of Parkinson's disease.

Schrag A, Modi S, Hotham S, Merritt R, Khan K, Graham L; A on behalf of the European Parkinson’s Disease Association.

J Neurol. 2018 May;265(5):1151-1157. doi: 10.1007/s00415-018-8817-8. Epub 2018 Mar 15.

12.

Mild Cognitive Impairment in Parkinson's Disease-What Is It?

Weil RS, Costantini AA, Schrag AE.

Curr Neurol Neurosci Rep. 2018 Mar 10;18(4):17. doi: 10.1007/s11910-018-0823-9. Review.

13.

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE, Pappa K, Pavisic I, Schade RN, Noyce AJ, Crutch SJ, O'Keeffe AG, Schrag AE, Morris HR.

Mov Disord. 2018 Apr;33(4):544-553. doi: 10.1002/mds.27311. Epub 2018 Feb 23.

14.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
15.

Reply: MRI findings of visual system alterations in Parkinson's disease.

Weil RS, McColgan P, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR.

Brain. 2017 Nov 1;140(11):e70. doi: 10.1093/brain/awx245. No abstract available.

16.

The Cats-and-Dogs test: A tool to identify visuoperceptual deficits in Parkinson's disease.

Weil RS, Pappa K, Schade RN, Schrag AE, Bahrami B, Schwarzkopf DS, Crutch SJ, O'Keeffe AG, Morris HR.

Mov Disord. 2017 Dec;32(12):1789-1790. doi: 10.1002/mds.27176. Epub 2017 Oct 4. No abstract available.

17.

Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM.

F1000Res. 2017 Aug 30;6:1604. doi: 10.12688/f1000research.11725.1. eCollection 2017. Review.

18.

Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations.

Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H, Kumar H, Banerjee R, Erro R, Bhidayasiri R, Schrag A, Zis P, Lim SY, Al-Hashel JY, Kamel WA, Martinez-Martin P, Ray Chaudhuri K.

Neuroepidemiology. 2017;49(1-2):1-17. doi: 10.1159/000478702. Epub 2017 Aug 12. Review.

19.

Depression and Anxiety in Parkinson's Disease.

Schrag A, Taddei RN.

Int Rev Neurobiol. 2017;133:623-655. doi: 10.1016/bs.irn.2017.05.024. Epub 2017 Jul 21. Review.

PMID:
28802935
20.

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA, Foltynie T, Davey Smith G; International Parkinson Disease Genomics Consortium, Schrag A, Lees AJ, Hardy J, Singleton A, Nalls MA, Pearce N, Lawlor DA, Wood NW.

PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.

21.

Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.

Lane CA, Parker TD, Cash DM, Macpherson K, Donnachie E, Murray-Smith H, Barnes A, Barker S, Beasley DG, Bras J, Brown D, Burgos N, Byford M, Jorge Cardoso M, Carvalho A, Collins J, De Vita E, Dickson JC, Epie N, Espak M, Henley SMD, Hoskote C, Hutel M, Klimova J, Malone IB, Markiewicz P, Melbourne A, Modat M, Schrag A, Shah S, Sharma N, Sudre CH, Thomas DL, Wong A, Zhang H, Hardy J, Zetterberg H, Ourselin S, Crutch SJ, Kuh D, Richards M, Fox NC, Schott JM.

BMC Neurol. 2017 Apr 18;17(1):75. doi: 10.1186/s12883-017-0846-x.

22.

Viral hepatitis and Parkinson disease: A national record-linkage study.

Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M.

Neurology. 2017 Apr 25;88(17):1630-1633. doi: 10.1212/WNL.0000000000003848. Epub 2017 Mar 29.

PMID:
28356465
23.

Parkinson disease.

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE.

Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13. Review.

PMID:
28332488
24.

Cognitive decline before diagnosis of Parkinson's disease - Authors' reply.

Schrag A, Weintraub D, Schott JM.

Lancet Neurol. 2017 Apr;16(4):262. doi: 10.1016/S1474-4422(17)30043-1. No abstract available.

PMID:
28327332
25.

Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration.

Skorvanek M, Martinez-Martin P, Kovacs N, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Foltynie T, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Aviles-Olmos I, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Huang J, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Tilley BC, Valkovic P, Goetz CG, Stebbins GT.

Mov Disord Clin Pract. 2017 Mar 11;4(4):536-544. doi: 10.1002/mdc3.12476. eCollection 2017 Jul-Aug.

26.

PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.

Noyce AJ, R'Bibo L, Peress L, Bestwick JP, Adams-Carr KL, Mencacci NE, Hawkes CH, Masters JM, Wood N, Hardy J, Giovannoni G, Lees AJ, Schrag A.

Mov Disord. 2017 Feb;32(2):219-226. doi: 10.1002/mds.26898. Epub 2017 Jan 16.

27.

Subtle motor disturbances in PREDICT-PD participants.

Noyce AJ, Schrag A, Masters JM, Bestwick JP, Giovannoni G, Lees AJ.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):212-217. doi: 10.1136/jnnp-2016-314524. Epub 2016 Dec 16.

28.

Rasch analysis of the carers quality of life questionnaire for parkinsonism.

Pillas M, Selai C, Schrag A.

Mov Disord. 2017 Mar;32(3):463-466. doi: 10.1002/mds.26877. Epub 2016 Nov 22.

PMID:
27873351
29.

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.

Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM.

Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.

30.

Serotonergic loss underlying apathy in Parkinson's disease.

Schrag A, Politis M.

Brain. 2016 Sep;139(Pt 9):2338-9. doi: 10.1093/brain/aww190. No abstract available.

PMID:
27559106
31.

Visual dysfunction in Parkinson's disease.

Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR.

Brain. 2016 Nov 1;139(11):2827-2843. doi: 10.1093/brain/aww175. Review.

32.

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations.

Perez-Lloret S, Ciampi de Andrade D, Lyons KE, Rodríguez-Blázquez C, Chaudhuri KR, Deuschl G, Cruccu G, Sampaio C, Goetz CG, Schrag A, Martinez-Martin P, Stebbins G; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2016 Jun 24;3(6):527-537. doi: 10.1002/mdc3.12384. eCollection 2016 Nov-Dec.

33.

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations.

Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P.

Mov Disord. 2016 Oct;31(10):1455-1465. doi: 10.1002/mds.26649. Review.

PMID:
27193358
34.

Challenges of modifying disease progression in prediagnostic Parkinson's disease.

Salat D, Noyce AJ, Schrag A, Tolosa E.

Lancet Neurol. 2016 May;15(6):637-48. doi: 10.1016/S1474-4422(16)00060-0. Epub 2016 Mar 16. Review.

PMID:
26993435
35.

Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations.

Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A; Movement Disorders Society Rating Scales Committee.

Mov Disord. 2016 Sep;31(9):1342-55. doi: 10.1002/mds.26572. Epub 2016 Mar 4. Review.

PMID:
26945525
36.

The prediagnostic phase of Parkinson's disease.

Noyce AJ, Lees AJ, Schrag AE.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):871-8. doi: 10.1136/jnnp-2015-311890. Epub 2016 Jan 11. Review.

37.

Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease.

Martinez-Martin P, Leentjens AF, de Pedro-Cuesta J, Chaudhuri KR, Schrag AE, Weintraub D.

Mov Disord. 2016 Mar;31(3):270-9. doi: 10.1002/mds.26522. Epub 2015 Dec 22. Review.

PMID:
26695691
38.

New clinical trials for nonmotor manifestations of Parkinson's disease.

Schrag A, Sauerbier A, Chaudhuri KR.

Mov Disord. 2015 Sep 15;30(11):1490-504. doi: 10.1002/mds.26415. Review.

PMID:
26371623
39.

Constipation preceding Parkinson's disease: a systematic review and meta-analysis.

Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):710-6. doi: 10.1136/jnnp-2015-311680. Epub 2015 Sep 7. Review.

PMID:
26345189
40.

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, Bower J, Burn D, Low P, Schrag A.

Qual Life Res. 2016 Jan;25(1):81-8. doi: 10.1007/s11136-015-1071-y. Epub 2015 Aug 12.

PMID:
26264781
41.

A new scale for the assessment of pain in Parkinson's disease.

Schrag A.

Mov Disord. 2015 Oct;30(12):1589-90. doi: 10.1002/mds.26353. Epub 2015 Jul 31. No abstract available.

PMID:
26230748
42.

Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of falls.

Schrag A, Choudhury M, Kaski D, Gallagher DA.

NPJ Parkinsons Dis. 2015 Jun 11;1:15011. doi: 10.1038/npjparkd.2015.11.

43.

Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Hall DA, Forjaz MJ, Golbe LI, Litvan I, Payan CAM, Goetz CG, Leentjens AFG, Martinez-Martin P, Traon AP, Sampaio C, Post B, Stebbins G, Weintraub D, Schrag A.

Mov Disord Clin Pract. 2015 May 22;2(2):127-134. doi: 10.1002/mdc3.12130. eCollection 2015 Jun. Review. No abstract available.

44.

Web-based assessment of Parkinson's prodromal markers identifies GBA variants.

Noyce AJ, Mencacci NE, Schrag A, Bestwick JP, Giovannoni G, Lees AJ, Hardy J.

Mov Disord. 2015 Jun;30(7):1002-3. doi: 10.1002/mds.26249. Epub 2015 May 13. No abstract available.

PMID:
25970725
45.

Assessment of Parkinson's disease levodopa-induced dyskinesia: a qualitative research study.

Lenderking WR, Mannix S, Petrillo J, Kenney C, Landrian A, Schrag AE.

Qual Life Res. 2015 Aug;24(8):1899-910. doi: 10.1007/s11136-015-0925-7. Epub 2015 Feb 6.

PMID:
25655015
46.

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Schrag A, Horsfall L, Walters K, Noyce A, Petersen I.

Lancet Neurol. 2015 Jan;14(1):57-64. doi: 10.1016/S1474-4422(14)70287-X. Epub 2014 Nov 27.

47.

Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A; MDS Committee on Rating Scales.

J Clin Sleep Med. 2014 Dec 15;10(12):1351-7. doi: 10.5664/jcsm.4300. Review.

48.

Review of diagnostic instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A; MDS Committee on Rating Scales.

J Clin Sleep Med. 2014 Dec 15;10(12):1343-9. doi: 10.5664/jcsm.4298. Review.

49.

Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Schrag A, Stebbins G.

Mov Disord Clin Pract. 2014 Sep 30;1(4):317-324. doi: 10.1002/mdc3.12088. eCollection 2014 Dec. Review.

50.

Imaging psychogenic movement disorders.

Mehta AR, Rowe JB, Schrag AE.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):402. doi: 10.1007/s11910-013-0402-z. Review.

Supplemental Content

Loading ...
Support Center